Roche, Cipla launch ‘Antibody Cocktail’ for treatment of mild to moderate COVID-19

Priced at Rs 59,750 per dose, the medicine consists of an amalgamation of Casirivimab and Imdevimab drugs. Cipla will take care of the distribution of the product.

https://ift.tt/eA8V8J from https://ift.tt/3oLjk4U
by -
Tags

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Punjab govt announces Rs 1 crore cash award to India men`s hockey team players from the state

Indian men's hockey team on Thursday morning created history at the Tokyo Olympics by winning a bronze, their first medal in 41 years fr...